226 related articles for article (PubMed ID: 19398228)
1. Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells.
Trappoliere M; Caligiuri A; Schmid M; Bertolani C; Failli P; Vizzutti F; Novo E; di Manzano C; Marra F; Loguercio C; Pinzani M
J Hepatol; 2009 Jun; 50(6):1102-11. PubMed ID: 19398228
[TBL] [Abstract][Full Text] [Related]
2. Hop bitter acids exhibit anti-fibrogenic effects on hepatic stellate cells in vitro.
Saugspier M; Dorn C; Thasler WE; Gehrig M; Heilmann J; Hellerbrand C
Exp Mol Pathol; 2012 Apr; 92(2):222-8. PubMed ID: 22146696
[TBL] [Abstract][Full Text] [Related]
3. Thymosin β4 inhibits PDGF-BB induced activation, proliferation, and migration of human hepatic stellate cells via its actin-binding domain.
Shah R; Reyes-Gordillo K; Rojkind M
Expert Opin Biol Ther; 2018 Jul; 18(sup1):177-184. PubMed ID: 30063851
[TBL] [Abstract][Full Text] [Related]
4. Caffeic acid phenethyl ester attenuates pro-inflammatory and fibrogenic phenotypes of LPS-stimulated hepatic stellate cells through the inhibition of NF-κB signaling.
Zhao WX; Wang L; Yang JL; Li LZ; Xu WM; Li T
Int J Mol Med; 2014 Mar; 33(3):687-94. PubMed ID: 24378685
[TBL] [Abstract][Full Text] [Related]
5. Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells
Li Z; Ding Q; Ling LP; Wu Y; Meng DX; Li X; Zhang CQ
World J Gastroenterol; 2018 Feb; 24(7):819-832. PubMed ID: 29467552
[TBL] [Abstract][Full Text] [Related]
6. Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells.
Chong LW; Hsu YC; Lee TF; Lin Y; Chiu YT; Yang KC; Wu JC; Huang YT
BMC Gastroenterol; 2015 Feb; 15():22. PubMed ID: 25886887
[TBL] [Abstract][Full Text] [Related]
7. Indole-3-carbinol enhances the resolution of rat liver fibrosis and stimulates hepatic stellate cell apoptosis by blocking the inhibitor of κB kinase α/inhibitor of κB-α/nuclear factor-κB pathway.
Ping J; Gao AM; Qin HQ; Wei XN; Bai J; Liu L; Li XH; Li RW; Ao Y; Wang H
J Pharmacol Exp Ther; 2011 Nov; 339(2):694-703. PubMed ID: 21862660
[TBL] [Abstract][Full Text] [Related]
8. Propranolol prevents liver cirrhosis by inhibiting hepatic stellate cell activation mediated by the PDGFR/Akt pathway.
Ding Q; Li Z; Liu B; Ling L; Tian X; Zhang C
Hum Pathol; 2018 Jun; 76():37-46. PubMed ID: 29514109
[TBL] [Abstract][Full Text] [Related]
9. Silibinin induces hepatic stellate cell cycle arrest via enhancing p53/p27 and inhibiting Akt downstream signaling protein expression.
Ezhilarasan D; Evraerts J; Sid B; Calderon PB; Karthikeyan S; Sokal E; Najimi M
Hepatobiliary Pancreat Dis Int; 2017 Feb; 16(1):80-87. PubMed ID: 28119262
[TBL] [Abstract][Full Text] [Related]
10. Serum Amyloid A Induces Inflammation, Proliferation and Cell Death in Activated Hepatic Stellate Cells.
Siegmund SV; Schlosser M; Schildberg FA; Seki E; De Minicis S; Uchinami H; Kuntzen C; Knolle PA; Strassburg CP; Schwabe RF
PLoS One; 2016; 11(3):e0150893. PubMed ID: 26937641
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of quercetin on the progression of liver fibrosis through the regulation of NF-кB/IкBα, p38 MAPK, and Bcl-2/Bax signaling.
Wang R; Zhang H; Wang Y; Song F; Yuan Y
Int Immunopharmacol; 2017 Jun; 47():126-133. PubMed ID: 28391159
[TBL] [Abstract][Full Text] [Related]
12. Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells.
Caligiuri A; De Franco RM; Romanelli RG; Gentilini A; Meucci M; Failli P; Mazzetti L; Rombouts K; Geerts A; Vanasia M; Gentilini P; Marra F; Pinzani M
Gastroenterology; 2003 Feb; 124(2):504-20. PubMed ID: 12557155
[TBL] [Abstract][Full Text] [Related]
13. Opioid-like compound exerts anti-fibrotic activity via decreased hepatic stellate cell activation and inflammation.
Day SA; Lakner AM; Moore CC; Yen MH; Clemens MG; Wu ES; Schrum LW
Biochem Pharmacol; 2011 Apr; 81(8):996-1003. PubMed ID: 21291870
[TBL] [Abstract][Full Text] [Related]
14. Ligustrazine attenuates oxidative stress-induced activation of hepatic stellate cells by interrupting platelet-derived growth factor-β receptor-mediated ERK and p38 pathways.
Zhang F; Ni C; Kong D; Zhang X; Zhu X; Chen L; Lu Y; Zheng S
Toxicol Appl Pharmacol; 2012 Nov; 265(1):51-60. PubMed ID: 23022513
[TBL] [Abstract][Full Text] [Related]
15. FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis.
Verbeke L; Mannaerts I; Schierwagen R; Govaere O; Klein S; Vander Elst I; Windmolders P; Farre R; Wenes M; Mazzone M; Nevens F; van Grunsven LA; Trebicka J; Laleman W
Sci Rep; 2016 Sep; 6():33453. PubMed ID: 27634375
[TBL] [Abstract][Full Text] [Related]
16. Silybin attenuates LPS-induced lung injury in mice by inhibiting NF-κB signaling and NLRP3 activation.
Zhang B; Wang B; Cao S; Wang Y; Wu D
Int J Mol Med; 2017 May; 39(5):1111-1118. PubMed ID: 28350048
[TBL] [Abstract][Full Text] [Related]
17. Rev-erb agonist and TGF-β similarly affect autophagy but differentially regulate hepatic stellate cell fibrogenic phenotype.
Thomes PG; Brandon-Warner E; Li T; Donohue TM; Schrum LW
Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):137-147. PubMed ID: 27840152
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Carotenoids for Their Antifibrogenic Effects in Hepatic Stellate Cells.
Bae M; Kim MB; Kang H; Park YK; Lee JY
Lipids; 2019 Jun; 54(6-7):401-410. PubMed ID: 31140624
[TBL] [Abstract][Full Text] [Related]
19. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
20. Silybin inhibits interleukin-1β-induced production of pro-inflammatory mediators in canine hepatocyte cultures.
Au AY; Hasenwinkel JM; Frondoza CG
J Vet Pharmacol Ther; 2011 Apr; 34(2):120-9. PubMed ID: 21395602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
